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INTRODUCTION 
Sushruta Samhita, one among the 
Brihatrayee (Three literature of Ayurveda), 
describes twelve types of Mutraghata. The word 
‘Mutraghata’ comprises of two different words 
i.e. ‘Mutra’ and ‘Aghata’, which stand for low 
urine output due to obstruction in the passage of 
urine. The sign and symptoms of Mutraghata is 
closely resemble with the Benign Prostatic 
Hyperplasia (BPH).[1] According to Ayurveda, 
Mutraghata is manifested due to deranged 
function of Apana Vayu along with the vitiation 
of Kapha and Pitta Dosha. The vitiated Doshas 
are produced in the body due to improper of 
Ahara Vihara (diet and activity or daily regimen), 
Ritu Parivartan (seasonal changes) and Vaya 
(advancement of age). Ultimately, they travel 
through Sukshma Srotasa and finally Doshas are 
settle down at the Kha Vaigunya (diseased area) 
i.e. Basti Pradesh (urinary bladder) and 
developed the clinical entity Mutraghata. The 
symptoms like retention of urine, incomplete 
voiding, dribbling, hesitancy etc. are found in 
Mutraghata.  
Benign Prostatic Hyperplasia (BPH) is 
most common lower urinary tract disorder in 
modern medicine. It is a non-malignant 
enlargement of the prostate gland caused by 
either excessive hyperplasia of prostatic tissue. 
It is an old age related disorder found in men 
and responsible for significant morbidity in 
older age groups which hamper the quality of 
life. The growth / neoplastic changes in the 
prostate gland occurs due to the changes in the 
level of hormonal imbalance especially 
androgens and oestrogens.[2] Incidence rates 
increase from 3 cases per 1000 man per year at 
the age 45–49 years, 38 cases per 1000 men per 
year by the age of 75–79 years which shows the 
vulnerability of the disease at terminal age. The 
treatment options in modern medicine is either 
by conservative treatment using drugs 
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(hormonal therapy, chemotherapy etc.) or 
surgical intervention like open prostatectomy, 
Transurethral resection of Prostate (TURP), 
cryotherapy etc. In case of hormonal therapy 
there are complications like loss of libido, 
impotence and gynecomastia. Despite of the 
extensive researches till date there is no 
complete therapy to manage Benign Prostatic 
Hyperplasia (BPH) in modern medicine. [3] 
Various treatment options like Shodhan 
Chikitsa and Shaman Chikitsa in form of Kashaya 
(decoction), Kalka (paste), Ghrita (medicated 
ghee) and Kshara (caustics) are mentioned 
under Mutraghata. Keeping to the consideration 
of line of management, the treatment methods 
which are adopted for Mutrakricchahara like 
Abhyanga, Niruha Basti, Snehapana, Uttara Basti, 
Seka, Pradeha, Virechana etc are advised for all 
varieties of Mutraghata. These procedures are 
being selected as per the predominance of 
individual Doshas. In Sushruta Samhita 
Nidigdhikaadi swaras, Amalaka swaras, Elayukta 
dhaatri swaras, Mustadi kalka, Abhayadi kalka, 
Balaadi kalka, Ervaru (Cucumber) kalka, 
Mutradosahara Ksheerapaaka, Mutrarakta 
yonidoshahara ghrita, Baladi ghrita, Mahabala 
ghrita, Patolyadi kshara are mentioned.[4] The 
drugs like Shatavaryadi kwatha, Vyoshadi 
churna, Pashanabhedadi churna, Punarnavadi 
mishraka sneha, Shwadanstra ghrita (Gokshuradi 
ghrita), Punarnavadi panyoga, Saptachchhadadi 
yavagu are found in Charak Samhita. [5] In 
Asthang Sangraha, the description of Kantakaari 
swaras, Duralabha swaras, Trapushadi kalka, 
Simhyadi kalka, Sasaindhava triphala kalka, 
Haritakyadi kwatha, Shringastaka 
Trinapanchamuladi kwatha, Pashanabhedadi 
kwatha, Dashamooladi ghrita, Tilvaka ghrita, 
Patala Kshara, Gokshura kantakari Siddha 
yavagu are found.[6] The specific formulations 
such as Dhanyaka-gokshura Ghrita, Dhanyaka-
gokshura kwatha, Kulatha sidhhha ghrita, Vidari 
ghrita are cited in Bhavprakash. [7] In the context 
of Mutraghata, Sharangadhara has given the 
descriptions of Chandraprabha vati, Gokshuraadi 
Guggulu and Changeri ghrita. [8]  
In this article total 10 research studies 
have been reviewed out of which 04 Matra Basti, 
04 with Oral Medication. Studies on Matra Basti 
and 02 studies on Uttara Basti which were 
carried out at IPGT & RA Jamnagar to find the 
effective modalities or formulations in the 
management of Mutraghata.  
MATERIAL AND METHODS 
Materials: Research works done on the 
management of Mutraghata were collected 
manually from the library of department of 
Shalya Tantra, and data available in Ayurveda 
database, on all PG/Ph.D. theses carried out at 
I.P.G.T. & R.A. Jamnagar.[9] 
Methods: After review of research work done on 
Mutraghata it was observed that most of the 
scholars have selected Matra Basti along with 
oral different formulations as mentioned in the 
classics. So the methodology adopted for Matra 
Basti and Uttara Basti is given as follow.  
BASTI PROCEDURE 
Poorva Karma (Preoperative measures) 
Patients were advised to pass the natural 
urges particularly stool and urine before 
procedure. All patients were advised for nil oral 
before the administration of Basti. 
Required Basti materials like Sterilised 
rubber catheter, 50cc syringe, gloves and gauze 
pieces etc. were kept ready before 
administration of Uttara Basti.  
Pradhana Karma (Operative measures) 
Patient was kept in left lateral position 
for Matra Basti and supine position for Uttara 
Basti. The selected oil /Ghrita was warmed up to 
room temperature. A lubricated rubber catheter 
was inserted in to the rectum and approximately 
60 ml of selected Ghrita / Tail was slowly 
administered with help of a plastic syringe. In 
case of Uttara Basti the genital area was cleaned 
with betadine followed by 30-50ml Tail was 
administered with help of a sterilised catheter. 
Patient was advised to inhale and exhale deeply 
and keep himself as relaxed as possible during 
administration. Basti was given for continuous 
21 days once a daily before breakfast. 
Pashchata Karma (Post-Operative measures) 
After Basti patient was advised to lie 
down in left lateral position for 10 minutes. 
Patient shifted to ward and hot water bag was 
provided for local Svedana at lower abdomen. 
Patient was advised to retain the Basti material 
for maximum time as possible. The 
Pratyagamana kala (retention time) of Basti was 
noted daily. Light diet was allowed after one 
hour.  
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RESULTS 
Clinical evaluation of Mustadi Kalpa in 
the management of Mutraghta. [10] The Clinical 
study was planned with aim to assess the 
efficacy of Mustadi Kalpa in the senile 
enlargement of prostate. Total 14 patients of 
Benign Prostatic Hyperplasia were selected and 
divided into 2 groups. In first group the patients 
having history of benign enlargement of prostate 
with chronic retention of urine without 
incontinence and with incontinence in second 
group. Mustadi Kalpa (Musta (Cyperus rotundus), 
Deodaru(Cedrus deodara), Haritaki(Terminalia 
chebula) and Yastimadhu (Glycyrrhiza glabra) in 
powder form orally 10 gm once in the morning 
was administered for 3 weeks with lukewarm 
water in Apana Kala (before breakfast). Diurnal 
frequency showed highly significantly (p< .001) 
relief and nocturnal frequency showed 
significant (p< .01) relief in both groups. In weak 
stream highly significantly (p<.001) 
improvement in first group and significant (p< 
.01) improvement was noticed in second group. 
In hesitancy and intermittency significant (p< 
.05) improvement was observed in first group 
where as significant (p< .01) improvement was 
noticed in second group. In incontinence highly 
significant (p< .001) improvement was noticed 
in second group. In the residual urine volume a 
significant (p< .01) improvement was observed 
in first group and highly significant (p < .001) 
improvement in patients of second group. Finally 
study concluded that Mustadi Kalpa is effective 
treatment for the symptomatic management of 
BPH.  
Role of Devdarvyadi Compound and Basti 
in the management of Mutraghata. [11] The aim of 
study was to evaluated the role of Devadarvyadi 
compound orally, Niruha Basti of Devadarvyadi 
Kwatha and Eranda Taila Anuvasan Basti in the 
management Mutraghata (BPH). Total 24 
patients of BPH were selected and equally 
divided in three groups. In group-A 
Devadarvyadi compound (Devadaru, Musta, 
Haritaki, Vastimadhu, Punarnava, Pashanbheda, 
Gokshura, Svetachandana, Kamala, Useera) orally 
in powder form 10gm/day with lukewarm water 
in Apana Kala (before food) for one month. 
Niruha Basti (80gm for Kwatha, 40g for Kalka of 
coarse powder of Devdarvyadi compound and 
120ml Erand Tail, Saindhava lavana 5gm) and 
Anuvasan Basti of Devadarvyadi Kwatha and 
Eranda Taila (100ml) was administrated 
alternate day for the duration of 8 days. In group 
B only Devadaryadi compound in powder form 
orally was given. In Group C only Niruha and 
Anuvasan Basti therapy was given. Nocturia was 
relieved by 83.11% in group A, by 79.20 % in 
group C and by 27.75 % in group B. Dysuria was 
relieved by 81.00 % in group A, 75 % in group C 
and by 31 % in group B. In Stream change 77.09 
% relief was seen in group C, 73.86 % in group A 
and by 36.70 % in group B. In Hesitancy 80.00 % 
relief was seen in group A, 25 % in group C and 
B. Urgency relieved completely in group A & B 
where as in group C relief seen was only 64 %. 
Dysuria disappeared completely in group A & B 
where as in group C relief was seen 27.53 % 
only. Incontinence was relieved 100 % in group 
A, 66.67 % in group C and 25 % in group B. 
Haematuria was relieved up to 100 % in group A 
& B, where as in group C 66.67 %. .Residual 
urine volume was reduced 87.90 % in group A, 
76.06 % in group C and 45.50 % in group B. The 
study concluded that Devdarvyadi Compound is 
an effective formulation for Mutraghata. 
Role of Punarnavadi Compound in the 
Management of Mutraghata w.s.r. to BPH. [12] The 
study planned with objective to evaluate the role 
of Punarnavadi compound as a safe and effective 
medical treatment for the Mutraghata w.s.r. to 
BPH. For that purpose 22 patients of Mutraghata 
were selected and divided into two groups. In 
group-A (n=12) Punarnavadi compound Vatee 
(Punarnava, Varuna, Gokshura, Pashanabheda) 
1g three times a day orally was given for 2 
months. In group-B (n=10) patients were treated 
with placebo therapy of empty capsule in a dose 
of 1g three times a day for two months as a 
control group. Average 50% and 5.88% relief 
was noticed in residual urine, average 50% and 
0% relief was noticed in mean urine flow rate, 
average 11.34% and 0.18% relief was noticed in 
total WBC count, average 21.59% and 1.0% 
relief was noticed in blood urea in group-A and 
group-B respectively. 
A Clinical Evaluation of Mahayavanala 
Roma Kshara and Uttara Basti of Tail in the 
Management of Mutraghata. [13] In this study 
Total 12 patients were registered. Initially the 
Patients were advised to follow the ‘Pathya’ 
regimen like, Takra, Ksira, Masuya, Dadhi, Mudga 
yusa and Usna jala. Mahayavanla Roma Ksara 
500mg BD orally given for 30 days in Apana Kala 
in capsule form and Uttar Basti of Tail 30-50ml 
which is mentioned under Vataja Mutrakriccha 
Chikitsa was given for 15 days. [14] The following 
ingredients were used for the preparation of Tail 
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i.e. (Tila taila, Goghrita, Gokshura, Pasanbheda, 
Jalakumbhi (Pistia stratiotes), Hapusa (Juniperus 
communis), Kantakari (Solanum surattense), Bala 
(Sida cordifolia), Shatavari (Asperagus 
racemosus), Rasna (Pluchea lanceolata), Varuna, 
Aparajita and Vidarigandhadi gana dravyas). 
after the completion of study, Relief in subjective 
complaints i.e. 50% in Nocturia, 55.55% in 
Straining to begin urination, 67.85% in weak 
stream, 42.84% in Difficulty to postpone 
urination, 56.09% in Prolongation of voiding 
time, 58.53% in Diurnal urination, 52.08% in 
feeling of Incomplete emptying were found. 
Residual urine volume was significantly reduced 
up to 58.46% whereas statistically highly 
significant result was found in increase in the 
mean urine flow rate (23.25%). 
Role of Mustadi Kalpa in the management 
of Mutraghata w.s.r. to Benign Prostatic 
Hyperplasia. [15] The study was designed with 
aim to find clinical efficiency of Mustadi Kalpa 
(Musta, Haritaki, Devadaru, Murva, Yashtimadhu) 
in Mutraghata (Benign Prostatic Hyperplasia). In 
this study 22 patients of Mutraghata were 
registered and treated with Mustadi Kalpa orally 
in powder form 10gm/day with lukewarm water 
in Apana Kala for 3 weeks. After assessment of 
total effect of therapy, significant relief on the 
subjective as well as in objective parameters was 
recorded. The subjective complaints were 
relived significantly in the range of 27 to 56 %. 
Residual urine volume was significantly reduced 
by 28.00% whereas statistically highly 
significant result was found in increase of 
22.55% in the mean urine flow rate. This therapy 
showed insignificant changes in prostate gland 
enlargement after treatment.  
A clinical study on the role of 
Devdarvyadi Kashaya and Dashamoola-Siddha-
Taila Uttara Basti in the management of 
Mutraghata w.s.r. to BPH.[16] In this study 
Devadarvyadi Kashaya (Devadaru, Musta, Murva 
(Marsdenia tenasissima), Haritaki and 
Yashtimadhu (Glycyrrhiza glabra) 40 ml BD 
orally for 30 days in Apana Kala and Dashamoola 
siddha Tail (Tila Tail & the drugs of Dashamoola) 
Uttara Basti was instilled into the bladder with 
starting dose 30ml per day for 3 days 
consecutively and later on increased to 50 ml for 
04days. Two sittings of seven days each were 
scheduled with a gap of seven days in between 
for the management of Mutraghata. For this 
study 15 patients were registered and after 
assessment it was observed that the symptoms 
of Mutraghata were relieved significantly in the 
range of 67 to 93%. Residual urine volume was 
significantly reduced by 81%, where as a 
significant increase of 46% was recorded in the 
mean Urine flow rate. In some cases mild to 
moderate regression in prostate gland was also 
recorded.  
Clinical evaluation of Gokshuradi Kalpa 
and Yoga Basti in the management of 
Mutraghata (w.s.r. to B.P.H.).This study was 
designed with aims to evaluate the clinical 
efficacy of Pathya, Gokshuradi Kalpa and Yoga 
Basti (Anuvasana Basti of Dashmooladi Tail and 
Niruha Basti of Dwipanchmooladi Kwatha) in the 
management of Mutraghata. [17] Total 28 patients 
were selected and they were divided into two 
groups, in group-A 14 patients treated with 
Gokshuradi Kalpa (Gokshura, Varuna, 
Pashanbheda (Bergenia lingulata), Shunthi 
(Zingiber officinale), Mahayavnala Roma Kshara, 
Sita) 6gm orally for 30 days in Apana Kala. In 
patients of group-B, 14 treated with Gokshuradi 
Kalpa and Yoga Basti. The duration of treatment 
of Yoga Basti was 8 days and two successive 
sittings with the gap of 7 days were done. After 
the completion of study period, significant relief 
was observed in subjective as well as objective 
parameters. Residual urine volume was reduced 
up to 79% where as significant increase (56%) 
was recorded in the mean urine flow rate. In 
consideration to weight of prostate gland, mild 
to moderate regression was found in some cases.  
A Comparative clinical study on efficacy 
of Mahayavanala Roma Kshara and Dhanyaka 
Gokshura Ghrita in the management of 
Vatashtheela (Benign Prostatic Hyperplasia).[18] 
Total 24 patients were registered among them 
10 patients were drop out. In group A (n=6) 
were completed the treatment with 
Mahayavanala (Zea Mays (Indian Corals) Roma 
Kshara capsule, 500 mg, BD for 45 days. In Group 
B (n=8) patients were treated with Orally 
Dhanyaka Gokshur Ghrita (Dhanyaka, Gokshura, 
Ghrita)) 10gm two times a day for 45 days. 
Group treated with Dhanyaka Gokshur Ghrita 
was found more effective in comparison to group 
treated with Mahayavanala Roma Kshara in 
relieving prostate symptoms score as per 
calculation of unpaired t test p=(<0.05). Residual 
urine volume was significantly reduced up to 
79%, where as a statistically significant increase 
i.e. 56% in mean urine flow rate was recorded. In 
some cases mild to moderate regression in the 
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prostate volume was also recorded in both the 
groups.  
Clinical Study on Mutraghata w.s.r. to 
Benign Prostatic Hyperplasia and its 
management with Gokshuradi Compound Vatee 
and Dhanyaka-Gokshura Ghrita. [19] The study 
was planned to evaluate the clinical efficacy of 
Gokshuradi compound Vatee orally and 
Dhanyaka Gokshura Ghrita Matra Basti in 32 
diagnosed patients of Mutraghata. All selected 
cases were randomly divided into three groups. 
In group-A Gokshuradi compound Vatee 
(Gokshuradi Guggulu added with Kwath dravyas 
Punarnava (Boerhavia diffusa) and Devadara) 
500 mg was given orally three times a day for 21 
days with lukewarm water after 1/2 an hour of 
taking food. In patients of group-B Dhanyaka 
Gokshura Ghrita Matra Basti 60 ml once a day for 
21 days just after lunch. In Group- C Gokshuradi 
Compound Vatee and Dhanyaka Gokshura Ghrita 
Matra Basti was given. Statistically highly 
significant improvement was observed in 
average urine flow rate by 39.52 % in Group-A, 
by 31.65 % in Group-B, by 55.68 % in Group-C. 
Significant improvement was observed in the 
size of prostate gland by 20.71 % in Group-A, by 
18.08 % in Group-B and by 24.89 % in Group-C. 
Insignificant change was observed over post 
voidal residual urine volume in Group-A. In 
Group B, post voidal residual urine volume 
reduced up to 23.91 % which was found 
statistically insignificant where as significant 
improvement was observed by 25.17 % in 
Group-C. In overall assessment of therapy, 
Moderate improvement was seen in 3 patients 
(30.00 %), 4 patients (40.00 %) and 7 patients 
(70.00 %) in group A, B, and C respectively. Mild 
improvement was observed in 7 patients (70.00 
%), 6 patients (60.00 %) and 3 patients (30.00 
%) in group-A, B, and C respectively. At the end 
of therapy, none of patient had got complete 
cure in any of three groups. Overall group-C 
(54.09 %) has shown better result than group-A 
(45.67%) and group-B (47.99 %) in all 
parameters. There was no any untoward effect 
or adverse drug reaction (ADR) recorded during 
the entire duration of therapy among all the 
patients. 
A Clinical Study on Kanchanar Guggulu 
and Matra Basti of Dhanyaka Gokshura Ghrita in 
the management of Mutraghata w.s.r. to Benign 
Prostatic Hyperplasia. [20] In this study total 30 
patients were selected and divided into three 
groups. In Group A Kanchanara Guggulu 
(Kanchnara (Bauhinia variegata Blume.), 
Triphala contains Haritaki (Terminalia chebula), 
Bibhitaki (Terminalia bellirica), Amalaki (Emblica 
officinalis), Trikatu contains Pippali (Piper 
longum), Maricha(Piper nigrum), Shunthi 
(Zingiber officinale), Varun (Crataeva nurvala), 
Ela (Eletaria cardamomum), Twaka 
(Cinnamomum zeylanicum), Tejpatra 
(Cinnamomum tamal), Guggulu (Comiphera 
mukul)) was administered in a dose of 500 mg, 
three times a day, orally with lukewarm water. 
In Group-B Dhanyaka Gokshura Ghrita 
(Dhanyaka (Coriandrum Sativum), Gokshura 
(Tribulus terrestris), Ghrita (Butyrum departum)) 
was administered 60 ml, once daily as Matra 
Basti in Apana Kala. In group-C combined 
therapy was administered. Total duration of 
therapy in each group was 21 days and follow up 
was done for one month. Maximum 
improvement in sign and symptoms of BPH was 
seen in 3 patients (33.34 %), 5 patients (55.56 
%) and 3 patients (33.34 %) in group A, B, and C 
respectively. Moderate improvement was seen in 
4 patients (44.44 %), 4 patients (44.44 %) and 4 
patients (44.44 %) in group A, B, and C 
respectively. Mild improvement was observed in 
1 patients (11.11 %), 0 patients (00.00%) and 2 
patients (22.22 %) in group A, B, and C 
respectively. The scholar was noted that none of 
patient had got complete cure and 1 patient was 
seen unchanged (11.11%) result in group A and 
better result was found in group B in all 
parameters.  
DISCUSSION 
 The Mutraghata is a broad term and it 
can be considered as a syndrome, because it 
covers most of the pathological entity of the 
urinary system and classified into twelve / 
thirteen types. Based on the clinical 
symptomatology, it can be correlated with 
benign prostatic hyperplasia (BPH).The exact 
aetiology of BPH is not yet clearly understood. 
The concept of nodular hyperplasia in pathology 
of BPH has been established but its exact cause is 
still not known clearly. In fact, the development 
of BPH is multi-factorial phenomenon as there is 
no strong evidence for risk factors like smoking, 
vasectomy, obesity or high alcohol intake for 
developing clinical features of BPH. The only 
true factors related to the development of the 
disease are age and hormonal status.  
Basti is considered as the most 
appropriate treatment for Vata predominant 
diseases. Mutraghata is an entity in which 
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vitiation of Vata Dosha takes place. In Basti 
therapy, Anuvasana Basti is indicated when Vata 
is vitiated with the involvement of Kapha and 
Pitta Doshas and the pathology is localized in the 
Basti pradesha (KUB region). Matra Basti is one 
kind of Anuvasana Basti in which the dose of 
Snehadravya is used in less quantity (maximum 
60 ml). It is further said that administration of 
Matra Basti improves the general condition of 
the patients (Balya), nourishes (Bhrihaniya) him, 
normalizes the function of Vata and makes 
natural urges of urination, defecation easy in 
diseased conditions. So in most of the research 
studies Anuvasana Basti was selected in one 
group of patients.  
In above research studies reviewed in 
this article, the drugs used are Mustadi Kalpa in 
which main ingredient is Musta having Mutrala, 
Balya, Shothahara, Jvaraghna, Vishaghna 
properties. Devadarvyadi Kashaya and 
Gokshuradi Kalpa are mainly having Deepana, 
Pachana, Mutrala, Vatanulomana, Shothahara 
action and it is supplemented by Rasayana, Balya 
effect which are essential properties in the 
management of Mutraghata. Dashamoola siddha 
Tail used for Uttara Basti as the ingredients of 
Dashamoola are well known for their 
Shothahara, Vatahara and Mutrala actions and 
the preparation in Tail also enhance the 
properties of the drugs as Taila is also known for 
its Vataharaguna. For the purpose of Yoga Basti, 
Dashamooladi Anuvasana Basti and 
Dwipanchmooladi Niruha Basti were used, as the 
drugs of Dashamoola are well known for their 
Shothahara, Vatahara and Mutrala properties. In 
Dhanyaka Gokshura Ghrita Matra Basti Dhaanyak 
(Coriandum sativum) having Tridoshaghna, 
Mutrala and Snigdha actions while Gokshura 
(Tribulus terrestris) contains Anulomana, Basti 
Shodhana, Vedana Sthaapana and Mutrala 
properties. In the addition to this, because of 
Ghrita is selected which is the best Sneha and 
having “Sanskaarasya- Anuvartana” property 
and also enhances action of the drugs processed 
with it. In Gokshuradi compound Vatee two more 
drugs were added i.e. Punarnavaa (Boerhavia 
diffusa) and Devadaaru (Cedrus deodara) in the 
classical formulation of Gokshuradi Guggulu as 
Kwatha Dravyas due to their potent Vata-
shamaka, Shothahara, Lekhana, Basti Shodhana 
and Mutrala action, considering for better result 
in Mutraghata. The entire ingredients in this 
formulation have Ushna Veerya, Kashaya, 
Madhura and Tikta Rasa, Ruksha, Ushna and 
Teekshna Guna and Katu Vipaaka. In the classic 
Kanchanar Guggulu was mentioned in 
management of Gandamala, Apachi, Arbuda, 
Granthi etc. It is made up of Kanchanar twak, 
Triphala, Trikatu, Varun, Ela, Twak, Patra. Due to 
its Vata-Kaphahara, Shothahara, Lekhana and 
Mutrala effect and the selected drugs are shown 
better result in Mutraghata. 
CONCLUSION 
The review of research studies 
conducted on Mutraghata showed that the 
Mutraghata (Benign Prostatic Hyperplasia) can 
be best treated with Ayurvedic formulations as 
mentioned. The best treatment in the geriatric 
age is Basti chikitsa, so Uttara Basti, Matra Basti 
and Yoga Basti used in these research studies 
shown the better improvement in the BPH. In 
most of the studies better improvements was 
noted in the symptoms like dysuria, hesitancy, 
nocturia and reduction of residual urine volume. 
Mild to moderate regression in the prostate 
volume was also recorded and noticeable point 
is the quality of life was improved in these 
studies. No any adverse effect of any drug was 
noted in these study means treatment 
mentioned in review studies was well tolerable. 
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